Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 15Gastrointestinal 10Gynecologic 9Genitourinary 9Breast 7Head & Neck 5CNS 4Sarcoma 3Myeloid 3Endocrine 3Other hematologic neoplasm 2NET 2Tumor-Agnostic 1Other neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 238Lymphoma 235Lymphoma, Non-Hodgkin 203Leukemia, Lymphocytic, Chronic, B-Cell 186Lymphoma, Large B-Cell, Diffuse 178Lymphoma, Follicular 173Lymphoma, B-Cell 112Lymphoma, Mantle-Cell 107Hodgkin Disease 105Leukemia, Myeloid, Acute 102Recurrence 97Multiple Myeloma 91Burkitt Lymphoma 90Leukemia 76Neoplasms 68Lymphoma, B-Cell, Marginal Zone 60Hematologic Neoplasms 59Myelodysplastic Syndromes 56Waldenstrom Macroglobulinemia 48Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma, T-Cell 42Lymphoma, T-Cell, Peripheral 36Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Leukemia, B-Cell 26Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 23Breast Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × Lymphoid × 90 days × Clear all
NCT04996875 2026-05-05

APEX

Cogent Biosciences, Inc.

Phase 2 Recruiting
140 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡